Letters Screening for prostate cancer

First, standardise the assay

BMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c5813 (Published 26 October 2010) Cite this as: BMJ 2010;341:c5813
  1. Ann-Marie R Howell, core trainee year 2, surgery1,
  2. Arie Parnham, specialist registrar, urology1,
  3. Omer Karim, consultant urologist1,
  4. Rajesh Kavia, specialist registrar, urology1
  1. 1Wexham Park Hospital, Slough SL2 4HL, UK
  1. ann.stone{at}imperial.ac.uk

With an increasingly mobile UK population, patients may be treated at more than one centre during their illness. Homogeneity in laboratory prostate specific antigen (PSA) tests is needed to prevent “overdiagnosis” and “overtreatment.”1

At the low end of the analytical range, age specific PSA values may trigger further assessment …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial